National Asset Management, Inc. Dynavax Technologies Corp Transaction History

National Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 15, 2023	SELL	$10.27 - $13.29 $3,081 - $3,986	-300 Reduced 2.78%	10,500 $111,000
Q4 2022 Feb 21, 2023	BUY	$10.27 - $13.29 $1,509 - $1,953	147 Added 1.38%	10,800 $114,000
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $16,602 - $29,159	-1,672 Reduced 13.57%	10,653 $112,000
Q2 2022 Aug 12, 2022	BUY	$7.45 - $12.83 $1,303 - $2,245	175 Added 1.44%	12,325 $156,000
Q1 2022 May 02, 2022	SELL	$9.75 - $14.44 $3,900 - $5,776	-400 Reduced 3.19%	12,150 $132,000
Q4 2021 Jan 28, 2022	BUY	$13.17 - $20.94 $9,877 - $15,705	750 Added 6.36%	12,550 $177,000
Q3 2021 Nov 16, 2021	BUY	$9.16 - $19.83 $108,088 - $233,993	11,800 New	11,800 $227,000

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.